BO-112 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)
Phase 2 · Basal Cell Carcinoma |
Highlight Therapeutics | BO-112 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|